Literature DB >> 350570

Oxantel-pyrantel in various regimens for the treatment of soil transmitted helminthiasis in rural and urban communities.

B D Cabrera, F S Sy.   

Abstract

204 individuals from a rural community were given a single dose of oxantel-pyrantel at 15mg/kg bodyweight and if still infected, 20mg/kg bodyweight, with cure rates of 100%, 53% and 71% for ascariasis, trichuriasis and hookworm infection, respectively. From an urban community, 124 patients were given the same drug either as 15mg/kg bodyweight given twice in one day, with an interval of about 12 hours, or 20mg/kg bodyweight given daily for 2 days. Cure rates obtained were 100% in both groups for ascariasis; 89.2% of those given the first regimen were cured of trichuriasis compared with 71.2% of those on the second. For trichuriasis, oxantel-pyrantel given twice, 12 hours apart, appears to be the best treatment schedule and further clinical trials using this regimen are suggested.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 350570     DOI: 10.2165/00003495-197800151-00016

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  3 in total

1.  Ascariasis control and/or eradication in a rural community in the Philippines.

Authors:  B D Cabrera; P V Arambulo; G P Portillo
Journal:  Southeast Asian J Trop Med Public Health       Date:  1975-12       Impact factor: 0.267

2.  A comparative trial of oxantel-pyrantel and mebendazole in multiple helminth infection in school children.

Authors:  A S Dissanaike
Journal:  Drugs       Date:  1978       Impact factor: 9.546

3.  Anthelmintic effect of oxantel pamoate and pyrantel pamoate suspension against intestinal nematode infestations.

Authors:  Han Jong Rim; Chang Yong Won; Sung Ik Lee; Jung Kyoo Lim
Journal:  Kisaengchunghak Chapchi       Date:  1975-12
  3 in total
  1 in total

Review 1.  Preclinical and Clinical Characteristics of the Trichuricidal Drug Oxantel Pamoate and Clinical Development Plans: A Review.

Authors:  Marta S Palmeirim; Sabine Specht; Ivan Scandale; Irene Gander-Meisterernst; Monika Chabicovsky; Jennifer Keiser
Journal:  Drugs       Date:  2021-04-30       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.